FdaApplication
ANDA 212625
Identifiers
- fda_app_no: ANDA212625
Properties
| Property | Value |
|---|---|
| applicant_name | MSN LABS PVT LTD |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALOXEGOL | NALOXEGOL | 12.5MG | TABLET;ORAL |
| NALOXEGOL | NALOXEGOL | 25MG | TABLET;ORAL |
2 products